| The Board of Directors of Milestone Medical Inc. (WAR: MMD, the “Company”, the “Issuer”) today announced the commencement of clinical trials for its epidural instrument at a second clinical site in the United States. This follows the Company’s recent announcement last week that it had started its pivotal clinical trial for the epidural instrument in the United States. The Board of Directors of the Company is very pleased to announce the second site for the Issuer’s clinical trials in the United States. This Pain Institute is led by one of the premiere anesthesiologists and interventional pain management specialists in the U.S. He is also a member of multiple national pain societies and has lectured extensively throughout the U.S. The Company appreciates the interest it has received from a variety of leading pain management clinics and key opinion leaders to participate in the Issuer’s pivotal clinical trial. Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”. |
| Data | Imię i Nazwisko | Stanowisko | Podpis | ||
| 2015-03-10 13:40:54 | Joseph D'Agostino | CFO |
